# A Study to Evaluate the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) Register

> **NCT05015998** · — · COMPLETED · sponsor: **Astellas Pharma Europe Ltd.** · enrollment: 45637 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **OTHER:** Non-interventional

## Key facts

- **NCT ID:** NCT05015998
- **Lead sponsor:** Astellas Pharma Europe Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-30
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 45637 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05015998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05015998, "A Study to Evaluate the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) Register". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05015998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*